Wolf Group Capital Advisors lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 67.4% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,109 shares of the healthcare conglomerate’s stock after selling 8,488 shares during the period. Wolf Group Capital Advisors’ holdings in UnitedHealth Group were worth $2,095,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Outfitter Financial LLC purchased a new stake in UnitedHealth Group in the 4th quarter valued at $25,000. Blue Bell Private Wealth Management LLC purchased a new position in UnitedHealth Group during the 4th quarter worth $29,000. Advocacy Wealth Management Services LLC raised its position in UnitedHealth Group by 75.8% during the 1st quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 25 shares during the last quarter. Cascade Investment Advisors Inc. raised its position in UnitedHealth Group by 100.0% during the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 30 shares during the last quarter. Finally, Tortoise Investment Management LLC increased its holdings in shares of UnitedHealth Group by 54.8% in the 4th quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 23 shares in the last quarter. Institutional investors own 87.48% of the company’s stock.
A number of brokerages have recently issued reports on UNH. Cowen increased their price target on shares of UnitedHealth Group from $512.00 to $596.00 in a report on Monday, April 18th. Sanford C. Bernstein downgraded shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 price target for the company. in a report on Thursday, May 26th. They noted that the move was a valuation call. Loop Capital assumed coverage on shares of UnitedHealth Group in a research note on Thursday, June 16th. They issued a “buy” rating and a $575.00 price objective on the stock. Credit Suisse Group increased their price objective on shares of UnitedHealth Group from $564.00 to $595.00 and gave the company an “outperform” rating in a research note on Monday, April 18th. Finally, Cowen increased their price objective on shares of UnitedHealth Group from $512.00 to $596.00 in a research note on Monday, April 18th. Three research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $555.73.
In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,273 shares of UnitedHealth Group stock in a transaction dated Thursday, June 23rd. The stock was sold at an average price of $499.00, for a total transaction of $635,227.00. Following the transaction, the executive vice president now owns 8,104 shares of the company’s stock, valued at approximately $4,043,896. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction dated Monday, May 16th. The shares were sold at an average price of $493.25, for a total value of $1,233,125.00. Following the transaction, the director now directly owns 1,220,000 shares in the company, valued at approximately $601,765,000. The disclosure for this sale can be found here. Insiders sold a total of 6,273 shares of company stock worth $3,065,752 in the last three months. 0.40% of the stock is currently owned by company insiders.
Shares of UNH opened at $513.63 on Friday. UnitedHealth Group Incorporated has a 1 year low of $383.12 and a 1 year high of $553.29. The company has a market cap of $481.87 billion, a price-to-earnings ratio of 28.11, a price-to-earnings-growth ratio of 1.54 and a beta of 0.83. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.78 and a current ratio of 0.78. The firm has a fifty-day moving average of $492.84 and a 200-day moving average of $492.36.
UnitedHealth Group (NYSE:UNH – Get Rating) last issued its quarterly earnings results on Thursday, April 14th. The healthcare conglomerate reported $5.49 EPS for the quarter, topping the consensus estimate of $5.40 by $0.09. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. The firm had revenue of $80.15 billion for the quarter, compared to analysts’ expectations of $78.77 billion. During the same period in the previous year, the business earned $5.31 earnings per share. UnitedHealth Group’s revenue for the quarter was up 14.2% compared to the same quarter last year. Analysts predict that UnitedHealth Group Incorporated will post 21.75 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, June 28th. Investors of record on Monday, June 20th were paid a $1.65 dividend. The ex-dividend date of this dividend was Thursday, June 16th. This represents a $6.60 dividend on an annualized basis and a yield of 1.28%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.45. UnitedHealth Group’s dividend payout ratio (DPR) is currently 36.12%.
About UnitedHealth Group: (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments. UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children’s health insurance and health care programs; health and dental benefits; and hospital and clinical services.
See also:
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Get Rating).
Receive News & Ratings for UnitedHealth Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.
.